Edwards Lifesciences ROA 2006-2018 | EW

Current and historical return on assets (ROA) values for Edwards Lifesciences (EW) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets. Edwards Lifesciences ROA for the three months ending September 30, 2018 was 16.54%.
Edwards Lifesciences ROA - Return on Assets Historical Data
Date TTM Net Income Total Assets Return on Assets
2018-09-30 $0.71B $5.96B 12.33%
2018-06-30 $0.66B $5.69B 11.59%
2018-03-31 $0.56B $5.83B 10.13%
2017-12-31 $0.58B $5.67B 11.07%
2017-09-30 $0.75B $5.49B 14.96%
2017-06-30 $0.72B $5.14B 15.26%
2017-03-31 $0.66B $4.78B 14.86%
2016-12-31 $0.57B $4.51B 13.61%
2016-09-30 $0.55B $4.34B 13.55%
2016-06-30 $0.53B $4.05B 13.36%
2016-03-31 $0.52B $3.85B 13.38%
2015-12-31 $0.50B $4.06B 13.17%
2015-09-30 $0.46B $3.88B 12.78%
2015-06-30 $0.44B $3.61B 12.60%
2015-03-31 $0.87B $3.49B 25.54%
2014-12-31 $0.81B $3.52B 25.24%
2014-09-30 $0.78B $3.35B 25.82%
2014-06-30 $0.76B $3.33B 27.06%
2014-03-31 $0.31B $2.65B 11.92%
2013-12-31 $0.39B $2.71B 15.75%
2013-09-30 $0.40B $2.53B 17.17%
2013-06-30 $0.40B $2.34B 17.45%
2013-03-31 $0.37B $2.30B 16.84%
2012-12-31 $0.29B $2.22B 13.70%
2012-09-30 $0.27B $2.20B 12.84%
2012-06-30 $0.25B $2.08B 12.33%
2012-03-31 $0.24B $2.00B 11.94%
2011-12-31 $0.24B $1.98B 12.00%
2011-09-30 $0.24B $1.98B 12.44%
2011-06-30 $0.24B $2.00B 12.66%
2011-03-31 $0.24B $1.93B 13.31%
2010-12-31 $0.22B $1.77B 13.00%
2010-09-30 $0.20B $1.73B 12.27%
2010-06-30 $0.23B $1.64B 14.11%
2010-03-31 $0.22B $1.60B 13.87%
2009-12-31 $0.23B $1.62B 15.29%
2009-09-30 $0.22B $1.60B 15.17%
2009-06-30 $0.18B $1.47B 12.85%
2009-03-31 $0.17B $1.36B 12.54%
2008-12-31 $0.13B $1.40B 9.49%
2008-09-30 $0.11B $1.38B 7.94%
2008-06-30 $0.10B $1.35B 7.76%
2008-03-31 $0.10B $1.31B 7.52%
2007-12-31 $0.11B $1.35B 8.77%
2007-09-30 $0.12B $1.30B 9.35%
2007-06-30 $0.12B $1.25B 9.38%
2007-03-31 $0.12B $1.25B 9.45%
2006-12-31 $0.13B $1.25B 10.51%
2006-09-30 $0.15B $1.24B 12.00%
2006-06-30 $0.12B $1.26B 9.60%
2006-03-31 $0.10B $1.24B 7.97%
2005-12-31 $0.08B $1.23B 6.88%
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $35.206B $3.435B
Edwards Lifesciences Corporation provides products and technologies to treat late-stage cardiovascular disease. The Company's products include tissue replacement heart valves, heart valve repair products, hemodynamic monitoring devices, angioscopy equipment, oxygenators, and pharmaceuticals. Edwards Lifesciences Corporation is headquartered in Irvine, California.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $96.884B 22.58
Intuitive Surgical (ISRG) United States $61.959B 60.96
Fresenius Medical Care AG KGaA (FMS) Germany $21.571B 14.59
IDEXX Laboratories (IDXX) United States $17.322B 49.47
ABIOMED (ABMD) United States $15.031B 108.01
DexCom (DXCM) United States $13.284B 0.00
Hologic (HOLX) United States $12.760B 19.70
Teleflex (TFX) United States $11.860B 26.92
Varian Medical Systems (VAR) United States $11.648B 28.99
STERIS (STE) United Kingdom $9.532B 25.29
Masimo (MASI) United States $6.392B 41.45
Penumbra (PEN) United States $4.899B 295.83
LivaNova (LIVN) United Kingdom $4.495B 28.85
Globus Medical (GMED) United States $4.283B 26.85
Integra LifeSciences Holdings (IART) United States $4.007B 19.52
Wright Medical Group (WMGI) Netherlands $3.610B 0.00
Cantel Medical (CMD) United States $3.301B 32.56
Inogen (INGN) United States $3.205B 69.18
Integer Holdings (ITGR) United States $2.612B 21.86
Tandem Diabetes Care (TNDM) United States $2.498B 0.00
Glaukos (GKOS) United States $2.188B 0.00
Halyard Health (AVNS) United States $2.145B 19.33
OPKO Health (OPK) United States $2.127B 0.00
Nevro (NVRO) United States $1.282B 0.00
Luminex (LMNX) United States $1.187B 42.94
Tactile Systems Technology (TCMD) United States $1.168B 185.91
Natus Medical (BABY) United States $1.151B 24.18
Pacific Biosciences Of California (PACB) United States $1.098B 0.00
CryoLife (CRY) United States $1.051B 91.74
Orthofix (OFIX) United States $0.983B 28.38
Accelerate Diagnostics (AXDX) United States $0.908B 0.00
Intersect ENT (XENT) United States $0.895B 0.00
Mesa Laboratories (MLAB) United States $0.832B 49.21
AngioDynamics (ANGO) United States $0.775B 25.16
ViewRay (VRAY) United States $0.747B 0.00
Veracyte (VCYT) United States $0.701B 0.00
AxoGen (AXGN) United States $0.614B 0.00
Si-Bone (SIBN) United States $0.505B 0.00
OrthoPediatrics (KIDS) United States $0.436B 0.00
Quotient (QTNT) Switzerland $0.403B 0.00
Oxford Immunotec Global (OXFD) United Kingdom $0.392B 0.00
Sientra (SIEN) United States $0.372B 0.00
Fluidigm (FLDM) United States $0.343B 0.00
GenMark Diagnostics (GNMK) United States $0.336B 0.00
Accuray (ARAY) United States $0.335B 0.00
SeaSpine Holdings (SPNE) United States $0.289B 0.00
IRadimed (IRMD) United States $0.282B 73.71
RTI Surgical (RTIX) United States $0.272B 42.90
Neuronetics (STIM) United States $0.253B 0.00
Pulse Biosciences (PLSE) United States $0.252B 0.00
Nuvectra (NVTR) United States $0.247B 0.00
Helius Medical Technologies (HSDT) United States $0.212B 0.00
T2 Biosystems (TTOO) United States $0.159B 0.00
Sensus Healthcare (SRTS) United States $0.131B 0.00
Ra Medical Systems (RMED) United States $0.110B 0.00
Ekso Bionics Holdings (EKSO) United States $0.105B 0.00
EDAP TMS (EDAP) France $0.077B 0.00
Biosig Technologies (BSGM) United States $0.074B 0.00
Alphatec Holdings (ATEC) United States $0.074B 0.00
Apollo Endosurgery (APEN) United States $0.074B 0.00
HTG Molecular Diagnostics (HTGM) United States $0.066B 0.00
Second Sight Medical Products (EYES) United States $0.061B 0.00
Vermillion (VRML) United States $0.060B 0.00
Titan Medical (TMDI) Canada $0.046B 0.00
Restoration Robotics (HAIR) United States $0.041B 0.00
OBALON THERPTCS (OBLN) United States $0.040B 0.00
Viveve Medical (VIVE) United States $0.038B 0.00
ConforMIS (CFMS) United States $0.037B 0.00
Microbot Medical (MBOT) United States $0.029B 0.00
Lianluo Smart (LLIT) China $0.026B 0.00
PAVmed (PAVM) United States $0.026B 0.00
DarioHealth (DRIO) Israel $0.022B 0.00
Dynatronics (DYNT) United States $0.022B 0.00
Neovasc (NVCN) Canada $0.020B 0.00
Bioanalytical Systems (BASI) United States $0.015B 71.00
Nanovibronix (NAOV) United States $0.013B 0.00
ENDRA Life Sciences (NDRA) United States $0.012B 0.00
Presbia (LENS) Ireland $0.009B 0.00
ReWalk Robotics (RWLK) Israel $0.009B 0.00
Allied Healthcare Products (AHPI) United States $0.008B 0.00
Atossa Genetics (ATOS) United States $0.008B 0.00
Avinger (AVGR) United States $0.007B 0.00
Cesca Therapeutics (KOOL) United States $0.007B 0.00
Sunshine Heart Inc (CHFS) United States $0.005B 0.00
Amedica (SINT) United States $0.005B 0.00
Check-Cap (CHEK) Israel $0.000B 0.00